Maritess Fusco
Nurse Practitioner · Hackensack, NJNPI 1104698653
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 295 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,502, 7.2 times the $487 reported in 2023. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 295 payments — averaging $23.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$929
- Johnson & Johnson$875
- Regeneron Healthcare Solutions, Inc.$790
- AstraZeneca$661
- E.r. Squibb & Sons, L.L.C.$505
- Merck$502
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,51594%
- Education$4246%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 55 | $929 |
| Johnson & Johnson | 19 | $875 |
| Regeneron Healthcare Solutions, Inc. | 15 | $790 |
| AstraZeneca | 22 | $661 |
| E.r. Squibb & Sons, L.L.C. | 38 | $505 |
| Merck | 22 | $502 |
| Taiho Oncology, Inc. | 25 | $467 |
| Bayer | 14 | $304 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $264 |
| Eisai Inc. | 11 | $190 |
| Astellas Pharma US Inc | 9 | $170 |
| Jazz Pharmaceuticals Inc. | 2 | $151 |
| Gilead | 1 | $125 |
| Amgen | 1 | $121 |
| Ipsen Biopharmaceuticals, Inc | 7 | $119 |
| AbbVie | 6 | $98 |
| EMD Serono, Inc. | 6 | $87 |
| Novartis | 4 | $81 |
| Array Biopharma Inc | 4 | $73 |
| Novocure Inc. | 3 | $59 |
| Deciphera Pharmaceuticals Inc. | 3 | $52 |
| Tersera Therapeutics LLC | 3 | $50 |
| Janssen Scientific Affairs, LLC | 4 | $48 |
| G1 Therapeutics, Inc. | 2 | $37 |
| Pharmacosmos Therapeutics Inc. | 2 | $35 |
| Immunocore Limited | 2 | $33 |
| Blueprint Medicines Corporation | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Acrotech Biopharma Inc. | 1 | $17 |
| Beone Medicines USA, Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Servier Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,939 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 25 | $290 |
| Prochlorperazine Maleate | 16 | $177 |
| Potassium Chloride | 12 | $64 |
| Prednisone | 14 | $35 |
| Levothyroxine Sodium | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Hackensack
- Nancy ElmannHackensack$12K
- Zoya ShirHackensack$12K
- Laure PierreHackensack$8K
- Joelle GagnonHackensack$8K
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.